EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Magnetoencephalography Reveals Neuroprotection of COVID-19 Vaccination in Nonhuman Primates

Jennifer Stapleton-Kotloski iD, Jared Rowland, April Davenport iD, Phillip Epperly, Maria Blevins, Dwayne Godwin, Daniel Ewing, Zhaodong Liang, Appavu Sundaram, Nikolai Petrovsky iD, Kevin Porter, John Sanders iD und 1 weitere

Vaccines · 20.06.2026 · 14 (6) · 543

DOI: 10.3390/vaccines14060543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 20.06.2026. Verfasst von Jennifer Stapleton-Kotloski und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Allergy and Infectious Diseases, Wake Forest University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: COVID-19, caused by the SARS-CoV-2 virus, can lead to widespread neurological and cognitive complications, even in the absence of significant structural brain abnormalities. Understanding the evolving health concerns in the context of viral infections is critical to service member readiness, fitness, and mission completion. The potential neuroprotective effects of SARS-CoV-2 vaccination remain underexplored.

Methods

Using a cross-sectional, non-human primate model (female cynomolgus macaques), we employed magnetoencephalography (MEG) to assess resting-state brain activity following vaccination with escalating doses of a novel psoralen-inactivated SARS-CoV-2 vaccine (PsIV) or a combination of PsIV and a DNA vaccine (prime boost), and subsequent challenge with the Delta variant (SARS-CoV-2 B.1.617.2). MEG scans were acquired 41 days after inoculation. Source series were constructed for 42 regions of interest for each subject, and band power was computed.

Results

Band power demonstrated substantial preservation of neural activity across multiple brain regions in vaccinated subjects compared to unvaccinated controls following viral challenge. Significantly lower power was observed across the brain at all bandwidths in the unvaccinated group relative to the prime boost group. As PsIV concentration increased, spectral power increased, with the prime boost group having the greatest power.

Conclusions

This approach not only underscores the role of vaccination in mitigating neuropathology but also highlights the capability of MEG to detect subtle yet significant changes in brain function that may be overlooked by other imaging modalities. These findings advance our understanding of vaccine-induced neuroprotection and establish MEG as a powerful tool for monitoring brain function in the context of viral infections.

Schlagwörter

Stichwörter der Autor:innen

COVID-19cynomolgus macaquemagnetoencephalographyneuroprotectionsource seriessynthetic aperture magnetometryvaccine

Autor:innen und Institutionen

  • Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
  • Department of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
  • Section on Infectious Diseases, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
  • Agile Vaccines and Therapeutics Department, Defense Infectious Diseases Directorate, Naval Medical Research Command, Silver Spring, MD 20910, USA.
  • Vaxine Pty Ltd., Warradale, SA 5046, Australia.
  • Defense Infectious Diseases Directorate, Naval Medical Research Command, Silver Spring, MD 20910, USA.

ORCID-Profile: Jennifer Stapleton-Kotloski, April Davenport, Nikolai Petrovsky, John Sanders, James Daunais

Förderung

  • NINDS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Wake Forest University School of Medicine
  • Defense Health Program, Research, Development, Test and Evaluation
  • National Institutes of Health
  • Wake Forest School of Medicine COVID-19 Research Project pilot
  • Wake Forest School of Medicine Translational Sciences Institute Ignition Funds
  • Defense Health Program Research, Development, Test and Evaluation supplemental COVID-19 funding

Zitieren

APA

Stapleton-Kotloski, J., Rowland, J., Davenport, A., Epperly, P., Blevins, M., Godwin, D., Ewing, D., Liang, Z., Sundaram, A., Petrovsky, N., Porter, K., Sanders, J., & Daunais, J. (2026). Magnetoencephalography Reveals Neuroprotection of COVID-19 Vaccination in Nonhuman Primates. Vaccines, 14(6), 543. https://doi.org/10.3390/vaccines14060543

Vancouver

Stapleton-Kotloski J, Rowland J, Davenport A, Epperly P, Blevins M, Godwin D, et al. Magnetoencephalography Reveals Neuroprotection of COVID-19 Vaccination in Nonhuman Primates. Vaccines. 2026;14(6):543. doi:10.3390/vaccines14060543

BibTeX
@article{StapletonKotloski2026,
  author = {Stapleton-Kotloski, Jennifer and Rowland, Jared and Davenport, April and Epperly, Phillip and Blevins, Maria and Godwin, Dwayne and Ewing, Daniel and Liang, Zhaodong and Sundaram, Appavu and Petrovsky, Nikolai and Porter, Kevin and Sanders, John and Daunais, James},
  title = {Magnetoencephalography Reveals Neuroprotection of COVID-19 Vaccination in Nonhuman Primates},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {6},
  pages = {543},
  doi = {10.3390/vaccines14060543}
}
Kostenlos starten →